REGENXBIO Inc. (RGNX) Operating income 2016–2025
REGENXBIO Inc. (RGNX) annual operating income history from SEC filings — each fiscal year as reported.
-$161.2MFY2025 · since FY2016: -$65.3M → -$161.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$161.2M | +30.9% |
| FY2024 | -$233.3M | +13.0% |
| FY2023 | -$268.1M | -2.0% |
| FY2022 | -$262.9M | -264.3% |
| FY2021 | $160.0M | +234.2% |
| FY2020 | -$119.2M | +20.0% |
| FY2019 | -$149.0M | -269.1% |
| FY2018 | $88.1M | +216.1% |
| FY2017 | -$75.9M | -16.1% |
| FY2016 | -$65.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RGNX financial trends
RGNX RevenueRGNX Net incomeRGNX Net marginRGNX Gross profitRGNX Gross marginRGNX Operating marginRGNX Operating cash flowRGNX Free cash flowRGNX Capital expendituresRGNX Return on equityRGNX Stock buybacksRGNX Dividends paidRGNX Total assetsRGNX Total liabilitiesRGNX Shareholders’ equityRGNX overview →